SEC Filing Summary: Neuralstem, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuralstem, Inc. on January 17, 2014, reporting an event that occurred on January 14, 2014. The filing discloses a presentation made by company representatives at the Biotech Showcase 2014 in San Francisco, California. The presentation slides are included as Exhibit 99.01.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely as a disclosure of a public presentation and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing is limited to the disclosure of the conference presentation under Regulation FD.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information contained in the report and the attached presentation slides shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the information is not subject to the liabilities of that section and is not incorporated by reference into other filings unless expressly stated. The filing does not provide specific management commentary, guidance, or risk factors beyond this legal disclaimer.
Key Facts for Investor Verification
- The registrant is Neuralstem, Inc., not Palisade Bio, Inc.
- The filing discloses a presentation at the Biotech Showcase 2014 on January 14, 2014.
- Investors should review Exhibit 99.01 (the presentation slides) for any forward-looking statements or strategic updates, noting these are not legally "filed" documents.
- No financial data or operational metrics are included in this specific 8-K filing.